Clinical Trials Logo

Clinical Trial Summary

Compare the abuse liabilities of Staccato Alprazolam, oral immediate-release alprazolam, and Staccato Placebo.


Clinical Trial Description

The Phase 1 clinical study compared the abuse liabilities of Staccato Alprazolam, oral immediate-release alprazolam, and Staccato Placebo in 14 subjects with a history of sedative abuse. Subjects who met the inclusion/exclusion criteria received 2 mg of oral alprazolam and matching placebo over 2 sessions. Those who demonstrated greater liking for alprazolam versus placebo were eligible to participate in the study. ;


Study Design


Related Conditions & MeSH terms

  • Abuse Liability of Staccato Alprazolam

NCT number NCT00603980
Study type Interventional
Source Alexza Pharmaceuticals, Inc.
Contact
Status Completed
Phase Phase 1
Start date January 2008
Completion date January 2009